| A minimal common outcome measure set for COVID-19 clinical research JC Marshall, S Murthy, J Diaz, NK Adhikari, DC Angus, YM Arabi, K Baillie, ... The lancet infectious diseases 20 (8), e192-e197, 2020 | 1074 | 2020 |
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual … SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ... The lancet Respiratory medicine 2 (5), 395-404, 2014 | 740 | 2014 |
| Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries H Getahun, A Matteelli, I Abubakar, MA Aziz, A Baddeley, D Barreira, ... European Respiratory Journal 46 (6), 1563-1576, 2015 | 715 | 2015 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 376 | 2017 |
| The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis L Martinez, O Cords, CR Horsburgh, JR Andrews, C Acuna-Villaorduna, ... The Lancet 395 (10228), 973-984, 2020 | 256 | 2020 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 229 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 229 | 2020 |
| Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 190 | 2016 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 188 | 2019 |
| Preventive therapy for latent tuberculosis infection—the promise and the challenges GJ Fox, CC Dobler, BJ Marais, JT Denholm International Journal of Infectious Diseases 56, 68-76, 2017 | 188 | 2017 |
| Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses S Gras, L Kedzierski, SA Valkenburg, K Laurie, YC Liu, JT Denholm, ... Proceedings of the National Academy of Sciences 107 (28), 12599-12604, 2010 | 188 | 2010 |
| The incidence of tuberculosis among adolescents and young adults: a global estimate KJ Snow, C Sismanidis, J Denholm, SM Sawyer, SM Graham European Respiratory Journal 51 (2), 2018 | 177 | 2018 |
| Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific JM Trauer, JT Denholm, ES McBryde Journal of theoretical biology 358, 74-84, 2014 | 173 | 2014 |
| Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study GB Migliori, PM Thong, JW Alffenaar, J Denholm, M Tadolini, F Alyaquobi, ... European Respiratory Journal 58 (5), 2021 | 160 | 2021 |
| Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia JT Denholm, CL Gordon, PD Johnson, SS Hewagama, RL Stuart, ... Medical Journal of Australia 192 (2), 84-86, 2010 | 146 | 2010 |
| Adolescent tuberculosis KJ Snow, AT Cruz, JA Seddon, RA Ferrand, SS Chiang, JA Hughes, ... The Lancet Child & Adolescent Health 4 (1), 68-79, 2020 | 145 | 2020 |
| Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 138 | 2021 |
| Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia AR Tramontana, B George, AC Hurt, JS Doyle, K Langan, AB Reid, ... Emerging infectious diseases 16 (7), 1068, 2010 | 138 | 2010 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 133 | 2022 |
| Risk of active tuberculosis in the five years following infection... 15%? JM Trauer, N Moyo, EL Tay, K Dale, R Ragonnet, ES McBryde, ... Chest 149 (2), 516-525, 2016 | 122 | 2016 |
Emma McBrydeAustralian Institute of Tropical Health and Medicine, James Cook University在 jcu.edu.au 的电子邮件经过验证
